{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:12:30Z","timestamp":1771373550596,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024QH200"],"award-info":[{"award-number":["ZR2024QH200"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071504"],"award-info":[{"award-number":["82071504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","award":["2021ZD0200600"],"award-info":[{"award-number":["2021ZD0200600"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","award":["2021ZD0202000"],"award-info":[{"award-number":["2021ZD0202000"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.neuropharm.2024.110286","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T16:43:15Z","timestamp":1735317795000},"page":"110286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clozapine and rapamycin reverse behavioral abnormalities in an animal model of autoimmune schizophrenia"],"prefix":"10.1016","volume":"266","author":[{"given":"Duilin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7277-1619","authenticated-orcid":false,"given":"Hui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuropharm.2024.110286_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.9758\/cpn.2013.11.3.144","article-title":"Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures","volume":"11","author":"Al-Amin","year":"2013","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110286_bib2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0022-3565(24)35047-5","article-title":"Characterization of MK-801-induced behavior as a putative rat model of psychosis","volume":"290","author":"Andin\u00e9","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110286_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10290","article-title":"Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal","volume":"69","author":"Bai","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110286_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65566-4","article-title":"Loss of dysbindin-1 in excitatory neurons in mice impacts NMDAR-dependent behaviors, neuronal morphology and synaptic transmission in the ventral hippocampus","volume":"14","author":"Bhardwaj","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2024.110286_bib5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3389\/fneur.2019.00804","article-title":"Cerebrospinal fluid findings in patients with autoimmune encephalitis-A systematic analysis","volume":"10","author":"Blinder","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110286_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/7854_2010_61","article-title":"Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia","volume":"4","author":"Braff","year":"2010","journal-title":"Curr Top Behav Neurosci"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110286_bib7","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.celrep.2014.10.053","article-title":"Genome-wide RNAi screen reveals a role for multipass membrane proteins in endosome-to-golgi retrieval","volume":"9","author":"Breusegem","year":"2014","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110286_bib8","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.1038\/tp.2016.44","article-title":"Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801","volume":"6","author":"Bygrave","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110286_bib9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/14728222.2016.1188080","article-title":"Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target","volume":"20","author":"Calabrese","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110286_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ph13120457","article-title":"Antioxidant properties of second-generation antipsychotics: focus on microglia","volume":"13","author":"Caruso","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110286_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101364","article-title":"Thyroid gland and brain: enigma of Hashimoto's encephalopathy","volume":"33","author":"Churilov","year":"2019","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110286_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biopsych.2018.06.016","article-title":"Associations between non-neurological autoimmune disorders and psychosis: a meta-analysis","volume":"85","author":"Cullen","year":"2019","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110286_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuroimage.2014.03.071","article-title":"Neuronal transport defects of the MAP6 KO mouse - a model of schizophrenia - and alleviation by Epothilone D treatment, as observed using MEMRI","volume":"96","author":"Daoust","year":"2014","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110286_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.02-06-00791.1982","article-title":"A primary acoustic startle circuit: lesion and stimulation studies","volume":"2","author":"Davis","year":"1982","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110286_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbi.2021.07.017","article-title":"Immune environment of the brain in schizophrenia and during the psychotic episode: a human post-mortem study","volume":"97","author":"De Picker","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110286_bib16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2215-0366(18)30345-6","article-title":"The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial","volume":"5","author":"Deakin","year":"2018","journal-title":"Lancet Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110286_bib17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.bbr.2012.01.017","article-title":"Blocking mTORC1 activity by rapamycin leads to impairment of spatial memory retrieval but not acquisition in C57BL\/6J mice","volume":"229","author":"Deli","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110286_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.25655","article-title":"Randomized placebo-controlled trial of intravenous immunoglobulin in autoimmune LGI1\/CASPR2 epilepsy","volume":"87","author":"Dubey","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110286_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fnhum.2015.00476","article-title":"Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients","volume":"9","author":"Endres","year":"2015","journal-title":"Front. Hum. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110286_bib20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1017\/S0033291720002895","article-title":"Autoantibody-associated psychiatric syndromes: a systematic literature review resulting in 145 cases","volume":"52","author":"Endres","year":"2022","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110286_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nbd.2006.12.003","article-title":"Rapamycin is a neuroprotective treatment for traumatic brain injury","volume":"26","author":"Erlich","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110286_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mp.2012.110","article-title":"Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia","volume":"18","author":"Fillman","year":"2013","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110286_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","article-title":"Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia","volume":"57","author":"Glantz","year":"2000","journal-title":"Arch. Gen. Psychiatr."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110286_bib24","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110286_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1461145712000144","article-title":"Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists","volume":"16","author":"Graham","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2024.110286_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbi.2023.10.001","article-title":"Changes in immunoglobulin levels during clozapine treatment in schizophrenia","volume":"115","author":"Griffiths","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110286_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/2045125318781475","article-title":"The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses","volume":"8","author":"Haddad","year":"2018","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2024.110286_bib28","article-title":"Autoantibody-associated psychiatric symptoms and syndromes in adults: a narrative review and proposed diagnostic approach","volume":"9","author":"Hansen","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.neuropharm.2024.110286_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.schres.2017.05.009","article-title":"Cognitive and functional deficits in people with schizophrenia: evidence for accelerated or exaggerated aging?","volume":"196","author":"Harvey","year":"2018","journal-title":"Schizophr. Res."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.110286_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2005.07.002","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol","volume":"519","author":"Hashimoto","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110286_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12888-024-05689-0","article-title":"Multiple serum anti-glutamate receptor antibody levels in clozapine-treated\/na\u00efve patients with treatment-resistant schizophrenia","volume":"24","author":"He","year":"2024","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110286_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fpsyt.2019.00131","article-title":"Autoimmune diseases and psychotic disorders","volume":"10","author":"Jeppesen","year":"2019","journal-title":"Front. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110286_bib33","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/schbul\/sbac098","article-title":"Cerebrospinal fluid and blood biomarkers of neuroinflammation and blood-brain barrier in psychotic disorders and individually matched healthy controls","volume":"48","author":"Jeppesen","year":"2022","journal-title":"Schizophr. Bull."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.110286_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jneuroim.2014.02.008","article-title":"Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia","volume":"269","author":"Jones","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110286_bib35","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ana.25552","article-title":"Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain function","volume":"86","author":"Jurek","year":"2019","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110286_bib36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","article-title":"Schizophrenia is a cognitive illness: time for a change in focus","volume":"70","author":"Kahn","year":"2013","journal-title":"JAMA Psychiatr."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110286_bib37","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/0961203319852153","article-title":"Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia","volume":"28","author":"Kanapathy","year":"2019","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110286_bib38","doi-asserted-by":"crossref","first-page":"e1186","DOI":"10.1038\/tp.2017.162","article-title":"Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia","volume":"7","author":"Kannan","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110286_bib39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2014.10.007","article-title":"Anti-NMDA receptor encephalitis, autoimmunity, and psychosis","volume":"176","author":"Kayser","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2024.110286_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbi.2017.10.020","article-title":"Anti gliadin antibodies (AGA IgG) related to peripheral inflammation in schizophrenia","volume":"69","author":"Kelly","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110286_bib41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41398-020-0838-2","article-title":"Rapamycin increases the incidence of neuropsychiatric illness in kidney transplant patients through the suppression of neural stem cells","volume":"10","author":"Kim","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.110286_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/7854_2010_117","article-title":"Sex differences and hormonal influences in human sensorimotor gating: implications for schizophrenia","volume":"8","author":"Kumari","year":"2011","journal-title":"Curr Top Behav Neurosci"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110286_bib43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.9758\/cpn.2021.19.4.618","article-title":"Alteration in Cngb1 expression upon maternal immune activation in a mouse model and its possible association with schizophrenia susceptibility","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.neuropharm.2024.110286_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2019.04.035","article-title":"Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg\/Th17 in a mouse model","volume":"705","author":"Li","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110286_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0893-133X(00)00137-8","article-title":"To model a psychiatric disorder in animals: schizophrenia as a reality test","volume":"23","author":"Lipska","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110286_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpsychires.2024.01.015","article-title":"Anti-SFT2D2 autoantibodies alter dendrite spine and cause psychotic behavior in mice","volume":"171","author":"Liu","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110286_bib47","first-page":"33","article-title":"Signs of impaired blood-brain barrier function and lower IgG synthesis within the central nervous system in patients with schizophrenia or related psychosis, compared to that in controls","volume":"39","author":"Melkersson","year":"2018","journal-title":"Neuroendocrinol. Lett."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110286_bib48","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations","volume":"44","author":"M\u00fcller","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110286_bib49","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0269881110364268","article-title":"Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now?","volume":"25","author":"M\u00fcller","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2024.110286_bib50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fnins.2015.00372","article-title":"The role of inflammation in schizophrenia","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110286_bib51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pbb.2011.02.009","article-title":"Effects of olanzapine, sertindole and clozapine on learning and memory in the Morris water maze test in naive and MK-801-treated mice","volume":"98","author":"Mutlu","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110286_bib52","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41380-018-0220-4","article-title":"Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis","volume":"24","author":"Orlovska-Waast","year":"2019","journal-title":"Mol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110286_bib53","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopsych.2005.07.031","article-title":"Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia","volume":"59","author":"Ozawa","year":"2006","journal-title":"Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110286_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nn.2741","article-title":"Dendritic spine pathology in neuropsychiatric disorders","volume":"14","author":"Penzes","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110286_bib55","first-page":"3144","article-title":"LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit-Pedrol","year":"2018","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110286_bib56","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00213-016-4246-5","article-title":"Serotonin depletion eliminates sex differences with respect to context-conditioned immobility in rat","volume":"233","author":"Pettersson","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110286_bib57","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.biopsych.2009.07.005","article-title":"Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia","volume":"66","author":"Piontkewitz","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110286_bib58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/7854_2011_195","article-title":"Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders","volume":"12","author":"Powell","year":"2012","journal-title":"Curr Top Behav Neurosci"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110286_bib59","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1460-9568.2003.02590.x","article-title":"The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis","volume":"17","author":"Qing","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"38","key":"10.1016\/j.neuropharm.2024.110286_bib60","doi-asserted-by":"crossref","first-page":"23242","DOI":"10.1073\/pnas.1820836117","article-title":"Critical period regulation across multiple timescales","volume":"117","author":"Reh","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110286_bib61","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/14740338.2016.1191468","article-title":"Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use","volume":"15","author":"Remington","year":"2016","journal-title":"Expet Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110286_bib62","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1021\/acschemneuro.6b00412","article-title":"Immune system activation and depression: roles of serotonin in the central nervous system and periphery","volume":"8","author":"Robson","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110286_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082226","article-title":"mTOR-related brain dysfunctions in neuropsychiatric disorders","volume":"19","author":"Ryskalin","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.neuropharm.2024.110286_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810806","article-title":"Recognition memory induces natural LTP-like hippocampal synaptic excitation and inhibition","volume":"23","author":"S\u00e1nchez-Rodr\u00edguez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.110286_bib65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2010.04.012","article-title":"Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice","volume":"59","author":"Scorza","year":"2010","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110286_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1192\/bjo.2018.8","article-title":"The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis","volume":"4","author":"Scott","year":"2018","journal-title":"BJPsych Open"},{"key":"10.1016\/j.neuropharm.2024.110286_bib67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.schres.2019.10.007","article-title":"Detection of autoantibodies against GABA(A)R\u03b11 in patients with schizophrenia","volume":"216","author":"Shiwaku","year":"2020","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110286_bib68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","article-title":"Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update","volume":"40","author":"Sommer","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110286_bib69","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.3892\/mmr.2015.4407","article-title":"Rapamycin protects neurons from brain contusion-induced inflammatory reaction via modulation of microglial activation","volume":"12","author":"Song","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110286_bib70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110286_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbr.2015.04.012","article-title":"Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease","volume":"289","author":"Stover","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110286_bib72","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/npp.2013.38","article-title":"Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia","volume":"38","author":"Takao","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110286_bib73","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00213-010-1944-2","article-title":"Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice","volume":"211","author":"Tammim\u00e4ki","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110286_bib74","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1113\/JP272134","article-title":"Microglia across the lifespan: from origin to function in brain development, plasticity and cognition","volume":"595","author":"Tay","year":"2017","journal-title":"J. Physiol."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110286_bib75","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/mp.2014.62","article-title":"Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory\/inhibitory imbalance hypothesis","volume":"19","author":"Tebartz van Elst","year":"2014","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110286_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbi.2019.06.017","article-title":"Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia","volume":"81","author":"Tong","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2024.110286_bib77","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.schres.2015.04.017","article-title":"Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: participation of antioxidant, nitrergic and neurotrophic mechanisms","volume":"165","author":"Vasconcelos","year":"2015","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110286_bib78","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S1461145708009371","article-title":"Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia","volume":"12","author":"Vigano","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2024.110286_bib79","article-title":"Rapamycin modulates the proinflammatory memory-like response of microglia induced by BAFF","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110286_bib80","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00213-004-1944-1","article-title":"Bimodal effects of MK-801 on locomotion and stereotypy in C57BL\/6 mice","volume":"177","author":"Wu","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2024.110286_bib81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuroscience.2010.10.041","article-title":"Inhibition of the mammalian target of rapamycin pathway by rapamycin blocks cocaine-induced locomotor sensitization","volume":"172","author":"Wu","year":"2011","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110286_bib82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12888-020-02509-z","article-title":"Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824004556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824004556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T16:34:07Z","timestamp":1740328447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824004556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":82,"alternative-id":["S0028390824004556"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110286","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine and rapamycin reverse behavioral abnormalities in an animal model of autoimmune schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110286"}}